# SCIINV

> Empowering Healthcare


## Posts

- [Received an honorary medal from the European Exhibition of Creativity and Innovation (EECI), IASI, Romania Chapter, in recognition of exemplary contributions to the medical domain and significant impact on human health through the development of the AMRx®️ solution, at the 23rd International Exhibition of Inventions (ARCA 2025), held in Zagreb, Croatia, from 16th to 18th October 2025.](https://sciinv.org/received-an-honorary-medal-from-the-european-exhibition-of-creativity-and-innovation-eeci/)
- [SCIINV Biosciences wins Gold medal in the Artificial intelligence Category at 38th International Exhibition of Inventions.](https://sciinv.org/sciinv-biosciences-wins-gold-medal-in-the-artificial-intelligence-category-at-38th-international-exhibition-of-inventions/): September 2–9, 2025 SCIINV Biosciences Wins Gold Medal in Artificial Intelligence at the 38th International Exhibition of Inventions, Belgrade SCIINV Biosciences is proud to announce that it has won the Gold Medal in Artificial Intelligence at the 38th International Exhibition of Inventions – Invention Week 2025, held at the Museum of Science and Technology in Belgrade and organized by the Belgrade Association of Inventors from September 2–9, 2025 . The award recognizes SCIINV Biosciences’ innovation AMRx® – a Culture-Free, AI/ML-Based Prediction Tool for Urinary Tract Infections and Antimicrobial Resistance. This breakthrough solution uses advanced AI and machine learning to rapidly […]
- [Received an honorary medal from the Filipino Inventors Society in recognition of contributions to advancing medical science for the benefit of mankind, through the development of the AMRx®️ solution, at Thailand Inventors Day (IPITEX), held in Bangkok, Thailand, from 5th to 9th January 2026.](https://sciinv.org/received-an-honorary-medal-from-the-filipino-inventors-society/)
- [Combating Antimicrobial Resistance:](https://sciinv.org/combating-antimicrobial-resistance/): Role of Key Stakeholders with Focus on the Pharmaceutical Sector AI in Diagnostics The medical diagnostic process is complex and prone to errors, influenced by clinician expertise, time constraints, and collaboration. Artificial intelligence advancements, including supervised, unsupervised, and DL algorithms, improve diagnostics by processing large datasets efficiently. Supervised learning uses labeled data for predictions, unsupervised learning finds patterns without labels, and deep learning addresses complex data but has interpretability issues. MALDI-TOF MS with ClinProTools software enables rapid and accurate identification of two S. aureus sub-species, achieving 100% accuracy through a genetic analysis and a quick classifier model [133]. The AMRx […]
- [AMRx® is Now a Registered Trademark in the U.K.](https://sciinv.org/amrx-is-now-a-registered-trademark-in-the-u-k/): We’re thrilled to share that AMRx is now a registered trademark in the (U.K.). This milestone marks another step forward in our global journey and reflects our continued commitment to innovation and excellence in healthcare.
- [SCIINV partners with UK-based Microbira to launch cutting-edge digital diagnostics aimed at combating superbugs in India.](https://sciinv.org/sciinv-partners-with-uks-microbira-ltd/): SCIINV Biosciences and UK-Based Microbira Partner to launch Cutting-Edge digital diagnostics to combat superbugs in India. The joint innovation AMRx® and MAAP IR is focused on early and precise pathogen identification, thereby minimizing the misuse of broad-spectrum antibiotics—a major driver of AMR, particularly in high-disease-burden regions like India.
- [AMRx® is now a registered international trademark under the Madrid Protocol, administered by WIPO.](https://sciinv.org/amrx-is-now-a-registered-international-trademark-under-the-madrid-protocol-administered-by-wipo/): We’re officially global!We are thrilled to announce that ‘AMRx®’ is now a registered international trademark under the Madrid Agreement and Protocol Treaty, administered by the World Intellectual Property Organization (WIPO).This achievement marks a major milestone in our journey — a testament to our unwavering focus on innovation, quality, and global expansion. Securing this international trademark strengthens the protection of our brand worldwide and lays a strong foundation for our continued growth in international markets.A big thanks you to our incredible team, partners and advisors who made this possible. Here’s to building a globally recognized, trusted brand that leads with purpose!
- [BW Businessworld Healthcare Excellence Award 2025 for the Innovative Solution AMRx®](https://sciinv.org/bw-businessworld-healthcare-excellence-award-2025-for-the-innovative-solution-amrx/): We are proud to announce that SCIINV Biosciences, in partnership with Innominds, has been honored with the BW Businessworld Healthcare Excellence Award 2025 for Excellence in Healthcare Innovation. This prestigious recognition celebrates AMRx®, a pioneering digital diagnostic tool designed to combat antimicrobial resistance (AMR). AMRx® is revolutionizing digital diagnostics with its AI/ML-driven UTI prediction tool, enabling faster, more accurate detection and improved patient outcomes. This award is a testament to our commitment to leveraging AI, deep tech, and advanced engineering to drive transformative healthcare solutions. A huge thank you to our partners, advisors, and collaborators for their unwavering support in […]
- [SCIINV Biosciences Wins Best Startup Award at HYSEA Summit & Awards 2025](https://sciinv.org/sciinv-biosciences-wins-best-startup-award-at-hysea-summit-awards-2025/): We are thrilled to announce that SCIINV Biosciences has been honored with the Best Startup Award at the prestigious HYSEA Summit & Awards 2025. This recognition is a testament to our unwavering commitment to scientific innovation and excellence in biotechnology. This achievement would not have been possible without the relentless dedication of our team, the invaluable guidance of our scientific advisors, and the steadfast support of our partners. We extend our sincere gratitude to HYSEA for recognizing our vision and selecting us for this esteemed award. At SCIINV Biosciences, we remain committed to pushing the boundaries of bioscience and delivering […]
- [AMRx® Featured in Microsoft Top 200 AI First Movers – Coffee Table Book](https://sciinv.org/amrx-featured-in-microsoft-top-200-ai-first-movers-coffee-table-book/): Fighting antibiotic resistance Antimicrobial resistance (AMR) is recognized by the World Health Organization (WHO) as one of the top ten global health threats, with severe implications for public health. Alarmingly, every 45 seconds, someone dies from an antibiotic resistant infection. AMRx® platform powered by Azure OpenAI is an advanced, culture-free, AI/ML based urinary tract infection (UTI) diagnostic tool. Analysing patterns AMRx utilises AL/ML and leverages patient clinical history to accurately predict UTIs, identify causative organisms, and determine antibiotic resistance or susceptibility patterns without the need for traditional cultures. Microsoft products used for the development of AMRx® are Azure Machine Learning, […]
- [SCIINV Biosciences and Innominds Win "The Economic Times Healthtech Solution of the Year Award 2024" for AMRx® Solution](https://sciinv.org/sciinv-biosciences-and-innominds-win-the-economic-times-healthtech-solution-of-the-year-award-2024-for-amrx-solution/): We are thrilled to announce that Innominds, in partnership with SCIINV Biosciences, has been honored with The Economic Times Healthtech Solution of the Year Award 2024 for the groundbreaking AMRx® solution at the prestigious The Economic Times Healthcare Awards! This award is a testament to our unwavering commitment to innovation and excellence in delivering cutting-edge healthcare solutions that are transforming the industry and improving patient outcomes. At SCIINV Biosciences, we are particularly proud of this recognition, as it comes at a critical time in the global fight against antimicrobial resistance (AMR), especially in light of the recent UNGA declaration on […]

## Pages

- [Terms of Use](https://sciinv.org/terms-of-use/): Terms of Use IntroductionThese Website Terms of Use (“Terms”) govern your use of the Sciinv website (the “Site”). By accessing and using this Site, you agree to comply with these Terms and our Privacy Policy. Use of the SiteYou agree to use this Site only for lawful purposes and in accordance with these Terms. You must not use the Site: In any way that violates any applicable laws or regulations. To transmit harmful content, such as viruses or malware. For any unauthorized commercial purpose. Intellectual PropertyAll content on this Site, including but not limited to text, images, logos, and software, […]
- [Privacy Policy](https://sciinv.org/privacy-policy/): Privacy Policy IntroductionAt Sciinv, we are committed to protecting your privacy. This Privacy Policy outlines how we collect, use, and safeguard your personal information when you visit our website. Information We CollectWe may collect the following types of personal information: Personal Identification Information – Name, email address, phone number, etc. Non-Personal Identification Information – Browser type, device type, usage data, etc. How We Use Your InformationWe use the information we collect for the following purposes: To improve our website and services. To personalize user experience. To respond to inquiries and provide customer support. To send marketing communications, if you opt-in. Data SecurityWe […]
- [Blog](https://sciinv.org/blog/): All Articles Awards News Trademarks AWARD Received an honorary medal from the Filipino Inventors Society in recognition of contributions to advancing medical science for the benefit of mankind, through the development of the AMRx®️ solution, at Thailand Inventors Day (IPITEX), held in Bangkok, Thailand, from 5th to 9th January 2026. Read More » November 19, 2025 AWARD Received an honorary medal from the European Exhibition of Creativity and Innovation (EECI), IASI, Romania Chapter, in recognition of exemplary contributions to the medical domain and significant impact on human health through the development of the AMRx®️ solution, at the 23rd International Exhibition […]
- [Patents](https://sciinv.org/patents/)
- [AMR Lab](https://sciinv.org/amr-lab/): Antimicrobial Resistance Laboratory (AMR Lab) State-of-the-Art Research for Advanced Solutions to Contain Antimicrobial Resistance Antimicrobial Resistance Laboratory (AMR Lab) The AMR laboratory at the Department of Biosciences, Sri Sathya Sai Institute of Higher Learning, Puttaparthi, Andhra Pradesh, India has the state-of-the-art facilities which includes BSL-2 Biosafety standards for Bacterial identification, antibiotic Susceptibility, Whole genome sequencing, Bio-informatics analyses, pathogen banking etc. Contact Us Dr. B.E. Pradeep Associate Professor, Sri Satya Sai Institute of Higher Learning
- [AMR Therapeutics](https://sciinv.org/amr-therapeutics/): AMR Therapeutics Gen AI based Drug Discovery Platform in silico in silico Virtual screening to identify target compounds through both ligand-based and structure-based approaches in vitro in vitro Leveraging extensive clinical metadata to screen and evaluate compounds and discovering new agents effective against microbial infections. in vivo in vivo In vivo testing on selected preclinical models to assess the safety, efficacy, pharmacokinetics, and pharmacodynamics of repurposed compounds in a biological system. “From Molecule to Model – Validating with Life” Developing novel antimicrobial drugs, by a rational approach taking into account the mechanisms of Antimicrobial drug Resistance by targeting the pathways […]
- [test](https://sciinv.org/test/)
- [AMRx](https://sciinv.org/amrx/): AMRx® The AI-Powered Solution Advanced, culture-free, AI/ML based Diagnostic Toolfor a new era of Anti Microbial Resistance Management AMRx®: The AI-Powered Solution AMRx® represents a groundbreaking advancement in AMR management, combining the power of artificial intelligence with patented technology. Our AI-driven diagnostics offer a revolutionary approach to detecting and managing antimicrobial resistance, providing precise, real-time insights that are essential for effective treatment and prevention. Patented Technology AMRx® utilizes a unique, patented technology that sets it apart from existing solutions (Indian Patent 0202241041495; Global PCT – PCT/IB2023/057299). This innovation ensures accuracy and reliability in diagnosing and predicting antimicrobial resistance. AI Integration […]
- [Contact us](https://sciinv.org/contact-us/): Connect with SCIINV Interested in learning more about AMRx® or exploring collaboration opportunities? We are here to help. Contact us today to see how our AI-based solutions can support your healthcare needs. Corporate Office SCIINV Biosciences Private LimitedFlat# 401, P No. 60 Abhis Hiranya Apartments, Kavuri Hills,Guttala Begumpet, HYDERABAD-500081, Telangana, India R&D Center SCIINV Biosciences Private Limited Room NO: 011, ASPIRE-BioNEST, 3rd Floor, School of Life Sciences, University of Hyderabad, Gachibowli, Hyderabad-500046 Contact Number +91 63024 47431 Email ceo@sciinv.org
- [Media](https://sciinv.org/media/): Media Talks and Press Notes Antimicrobial resistance (AMR) a major concern, say docs Doctors in the city have expressed serious concern over the growth in antimicrobial resistance (AMR) and the risks connected with it for various reasons despite a study showing antimicrobial resistance (AMR) contributed to 12.7 lakh fatalities in 2019. Read More Colloquium on State Action Plans on AMR in India 2022 Colloquium on State Action Plans on AMR in India 2022, held in Delhi on March 14th, 2022 It was a pleasure to meet with AMR containment warriors assembling from all over India to discuss the challenges in […]
- [About Us](https://sciinv.org/about-us/): Innovating Healthcare with AI At SCIINV, we are dedicated to harnessing the power of artificial intelligence to solve some of the most critical healthcare challenges. Recognized by Startup India (DIPP# 113811), our primary focus is on combating Antimicrobial Resistance through pioneering solutions like AMRx®. Our Purpose To provide innovative solutions to Antimicrobial Resistance (AMR) by leveraging cutting-edge AI-based technology and scientific research. We aim to address the growing global healthcare issues associated with AMR and offer breakthrough solutions that significantly impact patient outcomes and public health. Our Vision To create a world free from drug-resistant infections by safeguarding the health […]
- [Home](https://sciinv.org/): Welcome to SCIINV At SCIINV we are pioneering the future of healthcare through cutting-edge artificial intelligence. Our mission is to combat the growing global threat of Antimicrobial Resistance (AMR) with innovative solutions. Introducing AMRx®, our AI-based prediction tool designed to revolutionize diagnostics and empower healthcare professionals for timely diagnosis and successful treatments with data-driven insights. Join us in the fight against AMR and explore how AMRx® can make a difference in saving lives. Contact Us AMR – The Silent Global Threat: Why It Demands Immediate Action! AMR is a top global public health threat, estimated to have directly caused 1.27 […]


[comment]: # (Generated by Hostinger Tools Plugin)